VivoSeq
Other

Abdominoplasty

0

Pipeline Programs

0

Active Trials

3

Companies Involved

Abdominoplasty is an early-stage landscape with 0 programs across 3 companies. The most active players are Kythera Biopharmaceuticals, Tris Pharma, Inc., iX Biopharma Ltd..

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed10 · 67%
Unknown status3 · 20%
Terminated2 · 13%

Trial Activity

15 trials

ATX-101 Abdominoplasty
Completed·KKythera Biopharmaceuticals·Phase 1·NCT00835952·14 enrolled
Study in Subjects Undergoing Complete Abdominoplasty
Completed··Phase 2·NCT03789318·54 enrolled
Evaluation of N1539 Following Abdominoplasty Surgery
Completed·BBaudax Bio·Phase 3·NCT02678286·219 enrolled
Exparel vs. Standard Bupivicaine for Abdominoplasty
Terminated·EEmory University·Phase 4·NCT01853176·4 enrolled
Optimizing Recovery in Abdominoplasty
Terminated·UUniversity of Wisconsin, Madison·Phase 4·NCT04254692·2 enrolled
Transversus Abdominis Plane Blocks With Abdominoplasty
Unknown status··Phase 4·NCT01278264·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)